Taiwanese (TAIEX) Healthcare Dividend Stocks

UPDATED Feb 20, 2025

Discover Taiwanese Healthcare High Yield Dividend Stocks that are on the TAIEX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

68 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
4736
TaiDoc Technology
NT$141.500%-10.7%NT$13.4bn/aPE15.2xn/a7.1%
4138
Dynamic Medical Technologies
NT$91.301.2%0.4%NT$3.3bn/aPE16.9xn/a6.7%
7575
Amed
NT$42.002.6%-38.4%NT$1.2bn/an/an/a6.0%
4126
Pacific Hospital Supply
NT$91.400.6%4.3%NT$6.6bn/aPE16.1xE1.9%5.3%
6744
Feng Chi Biotech
NT$20.400.2%-10.7%NT$314.2mn/aPE16.3xn/a5.1%
3118
Level Biotechnology
NT$33.152.8%10.0%NT$1.1bn/aPE16.4xn/a5.1%
1788
Hi-Clearance
NT$145.000%6.6%NT$6.5bn/aPE17.4xn/a4.8%
4735
AViTA
NT$38.700.5%0.1%NT$1.3bn/aPE64.1xn/a4.7%
3373
Radiant Innovation
NT$23.601.9%-14.8%NT$1.0bn/aPS2.5xn/a4.2%
4173
Arich Enterprise
NT$21.85-0.7%-2.5%NT$1.6bn/aPE20.3xn/a4.2%
4104
Excelsior Medical
NT$86.700.5%3.7%NT$14.1bn/aPE18.5xn/a4.2%
4129
United Orthopedic
NT$97.00-0.2%-1.1%NT$9.4bNT$127.67PE20.6xS16.9%4.1%
7726
Carilex Medical
NT$42.950.2%n/aNT$872.1mn/an/an/a4.1%
4116
BenQ Medical Technology
NT$49.454.2%-17.3%NT$2.2bn/aPE19.1xn/a4.0%
6518
Concord Medical
NT$25.951.6%-0.4%NT$865.0mn/aPE18.4xn/a3.9%
1565
St.Shine OpticalLtd
NT$194.002.6%-3.2%NT$9.5bNT$247.25PE15.6xE17.9%3.6%
1733
Apex Biotechnology
NT$30.90-1.6%-7.1%NT$3.1bNT$36.00PE29.5xn/a3.6%
4164
CHC Healthcare Group
NT$57.101.4%-5.8%NT$9.2bn/aPE29.4xE62.3%3.5%
4183
EPS Bio Technology
NT$23.150.2%11.8%NT$551.0mn/aPE18.2xn/a3.5%
4107
Bioteque
NT$130.504.4%14.5%NT$8.6bn/aPE18.1xn/a3.4%
6747
Brighten Optix
NT$147.006.9%-9.9%NT$4.0bn/aPE26.7xn/a3.3%
4106
Wellell
NT$24.650.2%-14.0%NT$2.5bn/aPE26xn/a3.2%
4163
INTAI Technology
NT$112.503.2%-9.3%NT$5.5bn/aPE27.2xn/a3.1%
4737
Bionime
NT$64.40-2.4%-11.8%NT$4.0bn/aPS2xn/a3.1%
Page 1 of 3